DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Foran JM, Rohatiner AZS, Cunningham D. et al
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
J Clin Oncol 2000;
18 (02) 317-324
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.